Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue

被引:10
|
作者
Kubota, Takehiko [1 ]
Itagaki, Manarni [1 ]
Hoshino, Chika [1 ]
Nagata, Masaki [2 ]
Morozumi, Toshiya [1 ]
Kobayashi, Tetsuo [1 ,3 ]
Takagi, Ritsuo [2 ]
Yoshie, Hiromasa [1 ]
机构
[1] Niigata Univ, Grad Sch Med & Dent Sci, Course Oral Life Sci, Dept Oral Biol Sci,Div Periodontol, Niigata 9518514, Japan
[2] Niigata Univ, Grad Sch Med & Dent Sci, Course Oral Life Sci, Dept Oral Biol Sci,Div Oral & Maxillofacial Surg, Niigata 9518514, Japan
[3] Niigata Univ, Med & Dent Hosp, Gen Dent & Clin Educ Unit, Niigata, Japan
关键词
matrix metalloproteinases; periodontitis; tissue inhibitor of matrix metalloproteinase;
D O I
10.1902/jop.2008.070159
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: The balance between the degradation and synthesis of extracellular matrix determines periodontal attachment levels and alveolar bone matrix concentration in periodontal diseases. Matrix metalloproteinases (MMPs) are known to degrade periodontal ligamental attachment and bone matrix proteins. The purpose of this study was to examine the effect of different expression levels of MMPs and their inhibitors, the tissue inhibitors of matrix metalloproteinases (TIMPs), in periodontitis. Methods: Sixteen inflamed gingival tissue samples from subjects with generalized chronic periodontitis and 14 control tissue samples from systemically and periodontally healthy subjects were evaluated. The total RNA was extracted, and the transcript levels for MMP-1, -3, -9, and -13 and TIMP-1, -2, -3, and -4 relative to P-actin were determined by quantitative real-time reverse transcription - polymerase chain reaction. Results: Gene transcript levels for MMP-1 and TIMP-4 were significantly higher in periodontitis-affected gingival tissues (P <0.05). MMP-3, -9, and - 13 and TIMP-1 mRNAs also were elevated in periodontitis; however, the difference was not statistically significant. TIMP-2 and -3 mRNA levels were similar in healthy and diseased gingivae. The ratios of MMP-1 /TIMP-2 (P <0.01), MMP-3/TlMP-2 (P<0.05), MMP-9/TIMP-2 (P<0.05), and MMP-1/TIMP-3 (P<0.01) from periodontitis lesions were significantly higher than those in the control tissues. Conclusions: Upregulated MMP expression and an increased MMP/TIMP ratio indicate that a potential imbalance between degradation and synthesis of extracellular matrix persists in periodontitis-affected gingival tissues. This process may be responsible for increased tissue breakdown in periodontitis.
引用
收藏
页码:166 / 173
页数:8
相关论文
共 50 条
  • [41] Correlation between the Concentration of the Matrixmetalloproteinase-1 Tissue Levels and Clinical Parameters in Periodontitis-affected Patients
    Ristoska, Stevica
    Ivanovski, Kiro
    Panov, Sasho
    Stefanovska, Emilija
    Rendjova, Vasilka
    Pesevska, Snezana
    Mindova, Sonja S.
    Dirjanska, Katarina
    Georgieva, Silvana
    Pandilova, Maja
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2016, 7 (02): : 539 - 544
  • [42] IMMUNOLOCALIZATION OF MATRIX METALLOPROTEINASES AND TIMP-1 (TISSUE INHIBITOR OF METALLOPROTEINASES) IN HUMAN GINGIVAL TISSUES FROM PERIODONTITIS PATIENTS
    MEIKLE, MC
    HEMBRY, RM
    HOLLEY, J
    HORTON, C
    MCFARLANE, CG
    REYNOLDS, JJ
    JOURNAL OF PERIODONTAL RESEARCH, 1994, 29 (02) : 118 - 126
  • [43] Urinary levels of matrix metalloproteinases and their tissue inhibitors in nephrotic children
    Wasilewska, Anna M.
    Zoch-Zwierz, Walentyna M.
    PEDIATRIC NEPHROLOGY, 2008, 23 (10) : 1795 - 1802
  • [44] Clinical influence of calcium hydroxide intracanal medications on matrix metalloproteinases and tissue inhibitors of metalloproteinases in apical periodontitis
    Teixeira, Flavia F. C.
    Cardoso, Flavia G. R.
    Ferreira, Nadia S.
    Gomes, Ana P. M.
    Corazza, Bruna J. M.
    Valera, Marcia C.
    Martinho, Frederico C.
    CLINICAL ORAL INVESTIGATIONS, 2022, 26 (01) : 643 - 650
  • [45] Clinical influence of calcium hydroxide intracanal medications on matrix metalloproteinases and tissue inhibitors of metalloproteinases in apical periodontitis
    Flavia F. C. Teixeira
    Flavia G. R. Cardoso
    Nadia S. Ferreira
    Ana P. M. Gomes
    Bruna J. M. Corazza
    Marcia C. Valera
    Frederico C. Martinho
    Clinical Oral Investigations, 2022, 26 : 643 - 650
  • [46] Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations
    Hashimoto, T
    Wen, G
    Lawton, MT
    Boudreau, NJ
    Bollen, AW
    Yang, GY
    Barbaro, NM
    Higashida, RT
    Dowd, CF
    Halbach, VV
    Young, WL
    STROKE, 2003, 34 (04) : 925 - 930
  • [47] Urinary levels of matrix metalloproteinases and their tissue inhibitors in nephrotic children
    Anna M. Wasilewska
    Walentyna M. Zoch-Zwierz
    Pediatric Nephrology, 2008, 23 : 1795 - 1802
  • [48] Matrix metalloproteinases and their tissue inhibitors
    Timms, PM
    Campbell, S
    Srikanthan, V
    Price, CP
    BIOMARKERS OF DISEASE: AN EVIDENCE-BASED APPROACH, 2002, : 379 - 388
  • [49] Urinary levels of matrix metalloproteinases and their tissue inhibitors in nephrotic children
    Wasilewska, A.
    Zoch-Zwierz, W.
    Porowski, T.
    Korzeniecka-Kozerska, A.
    PEDIATRIC NEPHROLOGY, 2008, 23 (09) : 1635 - 1635
  • [50] Expression of Matrix Metalloproteinases, Tissue Inhibitors of Metalloproteinases, and Interleukins in Vertebral Cartilage Endplate
    Zhang, Jian-feng
    Wang, Gang-liang
    Zhou, Zhi-jie
    Fang, Xiang-qian
    Chen, Shuai
    Fan, Shun-wu
    ORTHOPAEDIC SURGERY, 2018, 10 (04) : 306 - 311